IO Biotech pockets Series B

IO Biotech, a Danish clinical-stage biopharmaceutical company, has raised 127 million euros in Series B financing.

IO Biotech, a Danish clinical-stage biopharmaceutical company, has raised 127 million euros in Series B financing. HBM Healthcare Investments led the round.

Source: Press Release